Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HART: Homocysteine Lowering and Atherosclerosis Reduction Trial
NCT00217178Phase 4Unknown
- Sponsor
- Hamilton Health Sciences
- Start
- Jan 2000
- Modality
- Orthosteric Ligands, Metabolically Activated Prodrugs
- Countries
- 1
01
Overview
A Phase 4 trial of folic acid, pyridoxine, cyanocobalamin in atherosclerosis, sponsored by Hamilton Health Sciences. Status: unknown.
02
Drugs
folic acidpyridoxinecyanocobalamin
03
Conditions
atherosclerosis
Beyond the preview
Go deeper on NCT00217178.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00217178.